{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:21:14Z","timestamp":1790716874241,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The prevalence of liver function abnormalities is common in patients with heart failure (HF) with reduced ejection fraction (HFrEF). We assessed the impact of liver function on prognosis and the effect of sacubitril\/valsartan on measures of liver function in patients with HFrEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The PARADIGM-HF trial was a randomized, double-blind, active treatment-controlled trial. We included 8232 HFrEF patients with available measures of liver function, including transaminases, alkaline phosphatase (ALP) and bilirubin; the primary endpoint was a composite of HF hospitalization and cardiovascular (CV) death. At screening, 11.6% of study patients had total bilirubin above the upper limit of normal (20.5\u2009\u03bcmol\/L) and 9.2% had ALP above the upper limit of normal (123\u2009IU\/L). Although ALP and albumin were associated with an increased risk of outcomes, among conventional test of liver function, total bilirubin was the strongest predictor for the primary endpoint [hazard ratio (HR) 1.10; 95% confidence interval (CI) 1.04\u20131.15; P\u2009&amp;lt;\u20090.001], HF hospitalization (HR 1.14; 95% CI 1.07\u20131.22; P\u2009&amp;lt;\u20090.001); CV death (HR 1.07; 95% CI 1.00\u20131.14; P = 0.040), and all-cause death (HR 1.08; 95% CI 1.02\u20131.14; P = 0.009). All conventional measures of liver function were significantly improved in the sacubitril\/valsartan group compared with the enalapril group after randomization (between-group reduction: total bilirubin 2.4%, 95% CI 0.7\u20134.2%, P = 0.007; aspartate aminotransferase 7.9%, 95% CI 6.7\u20139.0%, P\u2009&amp;lt;\u20090.001; alanine aminotransferase 7.7%; 95% CI 6.2\u20139.3%, P\u2009&amp;lt;\u20090.001; ALP 5.4%, 95% CI 4.4\u20136.4%, P\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Total bilirubin was a significant and independent predictor of CV death or HF hospitalization and all-cause mortality in patients with HFrEF enrolled in PARADIGM-HF. Sacubitril\/valsartan improved measures of liver function compared with enalapril.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.1853","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:24:15Z","timestamp":1589480655000},"page":"1662-1671","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Liver Function and Prognosis, and Influence of Sacubitril\/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction"],"prefix":"10.1093","volume":"22","author":[{"given":"Kota","family":"Suzuki","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Minamisawa","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute, Baylor University Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina and Ralph H. Johnson Department of Veterans Affairs Medical Center , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Rouleau","sequence":"additional","affiliation":[{"name":"University of Montreal , Montreal, Quebec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[{"name":"University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lefkowitz","sequence":"additional","affiliation":[{"name":"Novartis , East Hanover, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Shi","sequence":"additional","affiliation":[{"name":"Novartis , East Hanover, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Zucker","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"2026011721370103200_ejhf1853-bib-0001","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2018.10.063","article-title":"Interaction between gut microbiome and cardiovascular disease","volume":"214","author":"Peng","year":"2018","journal-title":"Life Sci"},{"key":"2026011721370103200_ejhf1853-bib-0002","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"2026011721370103200_ejhf1853-bib-0003","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721370103200_ejhf1853-bib-0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCULATIONAHA.106.678995","article-title":"The brain-heart connection","volume":"116","author":"Samuels","year":"2007","journal-title":"Circulation"},{"key":"2026011721370103200_ejhf1853-bib-0005","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721370103200_ejhf1853-bib-0006","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11897-014-0206-8","article-title":"Cardiohepatic syndrome: liver injury in decompensated heart failure","volume":"11","author":"Laribi","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"2026011721370103200_ejhf1853-bib-0007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721370103200_ejhf1853-bib-0008","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/oxfordjournals.eurheartj.a060785","article-title":"The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure","volume":"16","author":"Batin","year":"1995","journal-title":"Eur Heart J"},{"key":"2026011721370103200_ejhf1853-bib-0009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721370103200_ejhf1853-bib-0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lt.20906","article-title":"MELD-XI: a rational approach to \"sickest first\" liver transplantation in cirrhotic patients requiring anticoagulant therapy","volume":"13","author":"Heuman","year":"2007","journal-title":"Liver Transpl"},{"key":"2026011721370103200_ejhf1853-bib-0011","first-page":"82","article-title":"Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure","volume":"5","author":"Sern Lim","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026011721370103200_ejhf1853-bib-0012","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721370103200_ejhf1853-bib-0013","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721370103200_ejhf1853-bib-0014","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026011721370103200_ejhf1853-bib-0015","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2026011721370103200_ejhf1853-bib-0016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721370103200_ejhf1853-bib-0017","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jacc.2015.08.878","article-title":"Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF","volume":"66","author":"Simpson","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026011721370103200_ejhf1853-bib-0018","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamacardio.2019.5850","article-title":"Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure","volume":"5","author":"Simpson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026011721370103200_ejhf1853-bib-0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2026011721370103200_ejhf1853-bib-0020","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/modpathol.2015.40","article-title":"The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation","volume":"28","author":"Louie","year":"2015","journal-title":"Mod Pathol"},{"key":"2026011721370103200_ejhf1853-bib-0021","first-page":"447","article-title":"Chronic passive congestion of the liver in man. Electron microscopic study of cell atrophy and intralobular fibrosis","volume":"50","author":"Safran","year":"1967","journal-title":"Am J Pathol"},{"key":"2026011721370103200_ejhf1853-bib-0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9343(00)00461-7","article-title":"Ischemic hepatitis: clinical presentation and pathogenesis","volume":"109","author":"Seeto","year":"2000","journal-title":"Am J Med"},{"key":"2026011721370103200_ejhf1853-bib-0023","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0168-8278(94)80226-2","article-title":"Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow","volume":"21","author":"Henrion","year":"1994","journal-title":"J Hepatol"},{"key":"2026011721370103200_ejhf1853-bib-0024","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"2026011721370103200_ejhf1853-bib-0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"2026011721370103200_ejhf1853-bib-0026","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijcard.2014.08.052","article-title":"Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure","volume":"176","author":"Inohara","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026011721370103200_ejhf1853-bib-0027","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/heartjnl-2012-303347","article-title":"MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery","volume":"99","author":"Assenza","year":"2013","journal-title":"Heart"},{"key":"2026011721370103200_ejhf1853-bib-0028","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026011721370103200_ejhf1853-bib-0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"2026011721370103200_ejhf1853-bib-0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.1853","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.1853","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.1853","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/22\/9\/1662\/66111885\/eurjhf_22_9_1662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/22\/9\/1662\/66111885\/eurjhf_22_9_1662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:38:53Z","timestamp":1768703933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/22\/9\/1662\/8384614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,5,14]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.1853","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"2020-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}